HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Singson, C. N. Articles by Cross, J. H. Search for Related Content PubMed PubMed Citation Articles by Singson, C. N. Articles by Cross, J. H.

Mebendazole in the Treatment of Intestinal Capillariasis^*

A total of 131 hospitalized patients with Capillaria philippinensis infections were given mebendazole in doses ranging from 100 mg to 400 mg daily in single and divided doses for 10 to 30 days. Nearly all patients showed clinical improvement without side effects, but treatment failures occurred in a number of patients given 100 to 300 mg of the drug daily. No treatment failure occurred in new cases treated with 400 mg daily in divided doses for 20 days, but three failures occurred in old relapsed or chronic cases given the same dose for 30 days. However, the latter were successfully retreated with the same schedule. Mebendazole is presently considered the anthelminthic of choice for the treatment of this disease.

Accepted for publication April 12, 1975.

^* This study was supported in part by funds provided by the Philippine Health Department and the Bureau of Medicine and Surgery, U.S. Navy Department for Work Unit MF 51.524.009-0026A.

The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the Philippine Health Department or the U.S. Navy Department.

Address reprint requests to: Publications Office, NAMRU-2, Box 14, APO San Francisco 96263.